The combined entities will have 16 manufacturing plants out of which 10 are US Food and Drug Administration approved plants.
Viyash is already a qualified supplier for intermediates to Sequent for one of the largest active pharmaceutical ingredients (API) that Sequent manufactures for the US market
Viyash’s founder Haribabu Bodepudi who was formerly the chief operating officer of global drug major Mylan (now known as Viatris) hailed the combination.
Carlyle is a major shareholder of both companies.
; SeQuent Scientific acquired 3.90% of N-VET AB (Sweden) and 5% of Alivira Italia SRL (Italy), making both its wholly owned subsidiaries.
Top animal health companies